HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Diabetes & Endocrinology
Sys. Review
FGFR3 N540S variant exhibits phenotypic heterogeneity between proportionate short stature and hypochondroplasia
Genetic Testing Reveals New Variety of Short Stature Cause
This case report describes a 3-year-old male with proportionate short stature and his relatives who all harbored the heterozygous FGFR3 N540…
A new genetic finding shows that the same gene mutation can cause different types of short stature in different people.
Frontiers
Sep 3, 2026
Pediatrics
Phase II
Vosoritide daily injections in prepubertal hypochondroplasia patients over 12 months
Vosoritide Changes Growth Hormone Signals
This phase 2, single-arm, unblinded trial evaluated daily vosoritide 15 μg/kg in prepubertal patients aged 3 to 11 years with hypochondropla…
This new research shows how a specific growth medicine works inside the body to help short children grow taller.
Apr 22, 2026